Natural gas price stock UNG wobbles before the bell as Henry Hub slips — what traders watch next
14 January 2026
1 min read

Natural gas price stock UNG wobbles before the bell as Henry Hub slips — what traders watch next

NEW YORK, Jan 14, 2026, 06:39 EST — Premarket

  • UNG slipped roughly 0.3% in premarket, easing back after two solid days.
  • NYMEX Henry Hub February natural gas futures edged down early, hovering around $3.39 per mmBtu.
  • Traders are eyeing storage data due Thursday along with weather changes expected in late January.

The United States Natural Gas Fund (UNG), which follows daily changes in Henry Hub natural gas futures, dipped roughly 0.3% to $11.29 in premarket trading Wednesday, down from $11.32 at Tuesday’s close. Leveraged ETFs like ProShares Ultra Bloomberg Natural Gas (BOIL) usually show more volatile moves when gas prices shift. 1

NYMEX Henry Hub February natural gas futures slipped roughly 0.8% to $3.391 per million British thermal units (mmBtu) in early electronic trading. Henry Hub serves as the primary U.S. pricing hub for physical gas deliveries and acts as a key futures benchmark. 2

The U.S. Energy Information Administration slashed its Henry Hub price forecast for Q1 to an average of $3.38/mmBtu, down from $4.35 last month, due to expectations of milder-than-normal January weather reducing heating demand. In its latest Short-Term Energy Outlook, the EIA also forecast Henry Hub prices to hover just under $3.50/mmBtu in 2026, then climb to nearly $4.60/mmBtu by 2027 as LNG export capacity and power-sector demand tighten supply. The agency noted spot prices could slip below $3/mmBtu on Jan. 9. 3

Despite near-term caution, the EIA projects U.S. electricity consumption will hit new highs in 2026 and 2027, driven largely by data center demand. This matters for gas-fired generation at the margin. The agency predicts natural gas will power 39% of U.S. electricity in 2026 and 2027, a slight dip from 40% in 2025, as renewables continue to gain ground. 4

UNG has been volatile this month, caught between winter weather concerns and ample supply. It surged 7.5% on Jan. 12, then added 1.25% on Jan. 13, bouncing back from a sharp decline late last week. 5

Eli Rubin, an energy analyst at EBW Analytics Group, flagged forecasts turning colder late January as the main force behind Monday’s bounce in gas futures. He also cautioned that shifts in positioning might add fuel to short-term swings. Rubin highlighted LNG feedgas nominations hitting a record 20.4 billion cubic feet per day. Still, he described the likely trend as a “test higher and relent” scenario, with storage surpluses weighing on the market. 6

Commodity swings continue to drag on producers, even without fresh company-specific updates. EQT Corp shares dropped 1.07% Tuesday, settling at $51.59, lagging behind a mildly weaker broader market, MarketWatch data revealed. 7

The trade can flip quickly. If late January’s forecast warms up or storage reports reveal smaller withdrawals than expected, futures would probably take the hit first — dragging natural-gas trackers down alongside.

Thursday brings the next key data point with the U.S. storage report. The EIA will publish its Weekly Natural Gas Storage Report on Jan. 15 at 10:30 a.m. Eastern. The last update recorded a 119 billion cubic feet (Bcf) drawdown for the week ending Jan. 2, dropping working gas inventories to 3,256 Bcf. 8

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
XRP price today: Ripple-linked token rises as Washington’s crypto rules fight heats up
Previous Story

XRP price today: Ripple-linked token rises as Washington’s crypto rules fight heats up

Infosys Q3 results: Profit hit by labour codes, but FY26 guidance gets a lift
Next Story

Infosys Q3 results: Profit hit by labour codes, but FY26 guidance gets a lift

Go toTop